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Abstract
 
Pten is a tumor suppressor gene mutated in human cancers. We used the Cre-loxP system to
generate a B cell–specific mutation of Pten in mice (
 
bPten
 
flox/flox
 
mice). 
 
bPten
 
flox/flox
 
 mice showed
elevated numbers of B1a cells and increased serum autoantibodies. Among B2 cells in 
 
bPten
 
flox/flox
 
spleens, numbers of marginal zone B (MZB) cells were significantly increased while those of
follicular B (FOB) cells were correspondingly decreased. Pten-deficient B cells hyperprolifer-
ated, were resistant to apoptotic stimuli, and showed enhanced migration. The survival kinase
PKB/Akt was highly activated in Pten-deficient splenic B cells. In addition, immunoglobulin
class switch recombination was defective and induction of activation-induced cytidine deami-
nase (AID) was impaired. Thus, Pten plays a role in developmental fate determination of B cells
and is an indispensable regulator of B cell homeostasis.
Key words: PTEN • mutation • marginal zone B cells • class switch recombination • 
activation-induced cytidine deaminase
 
Introduction
 
PTEN
 
 is a tumor suppressor gene mutated in many human
sporadic cancers (1) and in hereditary cancer syndromes
such as Cowden disease and Bannayan-Zonana syndrome
(2, 3). Functionally, PTEN is a dual protein and lipid phos-
phatase (4, 5). The major substrate of PTEN is phosphati-
dyl inositol-3,4,5-triphosphate (PIP3),
 
*
 
 a second messenger
molecule produced through PI3
 

 
K activation induced by
growth factor stimulation. PIP3 activates the serine-threo-
nine kinase PKB/Akt which is involved in anti-apoptosis,
proliferation, and oncogenesis. PTEN negatively regulates
cell survival by dephosphorylating PIP3.
In previous work, we showed that a null mutation of
Pten in mice (
 
Pten
 

 
/
 

 
 mice; reference 6) is embryonic le-
thal. Using 
 
Pten
 

 
/
 

 
 mouse embryonic fibroblasts (MEFs),
we demonstrated that PKB/Akt is hyperactivated in the
absence of Pten (7). Furthermore, 
 
Pten
 

 
/
 

 
 mice frequently
develop lymphoid hyperplasia, T cell lymphomas, and en-
dometrial, prostatic, and breast cancers (6, 8, 9). Autoim-
mune disorders are also prevalent in 
 
Pten
 

 
/
 

 
 mice (10). In
T cell–specific Pten-deficient mice, we showed that CD4
 

 
lymphomas and autoimmune disorders arise due to im-
paired thymic negative selection and peripheral tolerance
(11). Since Pten mutations occur in human B cell malig-
nancies (12–14), we investigated the role of Pten in B
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cell development and B cell–associated autoimmunity
and oncogenesis.
B cells can be classified as either B1 or B2 cells. B1 cells
occur mainly in the pleural and peritoneal cavities and are
associated with the production of autoreactive antibodies
(15). B2 cells are found chiefly in the periphery and com-
prise transitional T1 and T2 cells, and mature follicular B
(FOB) cells and marginal zone B (MZB) cells. FOB cells
form the follicular structures of the secondary lymphoid or-
gans and are capable of recirculation. The much smaller
MZB fraction resides in the spleen at the boundary be-
tween the red pulp and white pulp (16). These cells may be
the first splenocytes to encounter blood-borne bacterial
pathogens (16, 17). Splenic MZB cells, but not FOB cells,
have high levels of surface immunoglobulin M (IgM) and
the complement receptor CD21, and low levels of IgD and
CD23 (18, 19). Both MZB and FOB cells undergo immu-
noglobulin class switching in response to antigen stimula-
tion and cytokines (20). Class switch recombination (CSR)
requires the activity of the RNA editing enzyme AID (21)
but the underlying mechanism is unknown.
To investigate the role of Pten in B cells, we generated
 
bPten
 
flox/flox
 
 mice using the Cre-loxP system. We report that
Pten governs B cell subsets especially in B1, FOB, and
MZB cells and is required for normal immunoglobulin
class switching.
 
Materials and Methods
 
Generation of bPten
 
flox/flox
 
 Mice. Pten
 
flox/flox
 
 mice (C57BL6/J
background) were mated to 
 
CD19Cre
 
 transgenic mice (C57BL6/J
background; reference 22) in which expression of Cre is con-
trolled by the endogenous promoter of the B cell–specific gene
CD19. Offspring carrying 
 
CD19Cre
 
 and two copies of the floxed
 
Pten
 
 allele (CD19CrePten
 
flox/flox
 
), 
 
CD19Cre
 
 plus one copy of the
floxed 
 
Pten
 
 allele (CD19CrePten
 
flox/
 

 
), and 
 
CD19Cre
 
 plus two
copies of the WT 
 
Pten
 
 allele (CD19CrePten
 

 
/
 

 
) were used in the
analyses as homozygous mutant (
 
bPten
 
flox/flox
 
), heterozygous mu-
tant (
 
bPten
 
flox/
 

 
), and wild type (
 
bPten
 

 
/
 

 
) mice, respectively.
 
PCR Analysis of Pten Genotypes.
 
Genomic DNA from mouse
tails was isolated and amplified by PCR following a published
protocol (6). Sense primer (5
 

 
-GTCACCAGGATGCTTCT-
GAC-3
 

 
) and antisense primer (5
 

 
-GAAACGGCCTTAAC-
GACGTAG-3
 

 
) were used to detect the floxed 
 
Pten
 
 allele; sense
primer (5
 

 
-GTCACCAGGATGCTTCTGAC-3
 

 
) and antisense
primer (5
 

 
-GTGACATCAACATGCAACACTG-3
 

 
) were used
to detect the WT 
 
Pten
 
 allele; and sense primer (5
 

 
-CTCCT-
CACCTGTCTCTTCTG-3
 

 
) and antisense primer (5
 

 
-TTC-
CATGAGTGAACGAACCTGGTCG-3
 

 
) were used to detect
the 
 
CD19Cre
 
 transgene. Amplified fragments of 512, 413, and
about 500 bp, respectively, were obtained.
 
Southern and Western Blots.
 
Genomic Southern blots were
performed using a previously described probe and protocol (6).
For Western blots, B cells (2 
 

 
 10
 
6
 
) were either left untreated or
stimulated with 10 
 

 
g/ml anti-IgM (ICN Biomedicals/Cappel).
Total cell lysates were prepared and 10 
 

 
g lysate aliquots analyzed
by Western blotting as described (7). Antibody directed against
the NH
 
2
 
 terminus of Pten and anti-actin antibody were from
Santa Cruz Biotechnology, Inc.; anti-phospho-PKB/Akt
(Ser473) and anti-total Akt/PKB antibodies were from New En-
gland Biolabs, Inc. For PI3
 

 
K inhibition studies, an optimal
amount of wortmannin (200 nM; Sigma-Aldrich) or LY294002
(50 
 

 
M; Sigma-Aldrich) as determined in pilot studies was added
15 min before stimulation.
 
Flow Cytometric Analysis and Cell Purification.
 
Single cell sus-
pensions were first incubated with anti-CD16/32 to minimize
nonspecific staining. Cells were then stained with cocktails of var-
ious mAbs conjugated to FITC, PE, or biotin for 20 min at
4
 

 
C. Biotinylated mAbs were developed with streptavidin-
Cy-Chrome (BD Biosciences). All mAbs, except PE-labeled anti-
IgD (Southern Biotechnology Associates, Inc.), were purchased
from BD Biosciences. Flow cytometric analysis was performed us-
ing a FACSCalibur™ (Becton Dickinson) with CELLQuest™
software (Becton Dickinson). Total splenic B cells were purified
using B220 magnetic beads (Macs; Miltenyi Biotec). Splenic
CD23
 
high
 
CD21
 
low
 
 B cells and CD23
 
low
 
CD21
 
high
 
 B cells were pu-
rified using B220 magnetic beads followed by cell sorting with a
FACSVantage™ (Becton Dickinson) after staining with anti-
CD21/35-FITC and anti-CD23-PE antibodies (BD Biosciences).
 
Histological Analysis of Splenic Sections.
 
For immunohisto-
chemical staining, freshly dissected spleens were covered with
Tissue-Tek OCT compound (Miles, Inc.) and quickly frozen in
liquid nitrogen. Frozen sections (7-
 

 
m thick) were fixed in ice
cold acetone and incubated in 3% H
 
2
 
O
 
2
 
 in 50% methanol for 30
min to inactivate internal peroxidase. Immunofluorescent staining
was performed using MOMA-1 (Serotec) and anti–rat Alexa488
(Molecular Probes) antibodies followed by anti-B220-PE (BD
Biosciences) staining. Immunohistochemical staining was per-
formed using biotin-conjugated peanut agglutinin (PNA; Seika-
gaku Kogyo) followed by a Vectastain ABC Elite kit (Vector
Laboratories).
 
Analysis of Humoral Responses.
 
Serum Ig isotype concentra-
tions were analyzed by ELISA as described (23). Abs and standard
Igs were purchased from Southern Biotechnology Associates, Inc.
For T cell–dependent immune responses, mice were immunized
with 100 
 

 
g of alum-precipitated chicken 
 

 
-globulin (CG) cou-
pled to 4-hydroxy-3-nitro-phenylacetyl (NP). For T cell–inde-
pendent immune responses, mice were immunized with 100 
 

 
g
of alum-precipitated Ficoll coupled to NP. In both cases, mice
were bled at 7 and 14 d after challenge. Serum titers of NP-spe-
cific IgM, IgG1, and IgG3 were determined by ELISA as de-
scribed (23). The measurement of serum anti-ssDNA IgG and
IgM antibodies was performed using ELISA as described (24). Sta-
tistical analyses were performed using the unpaired Student’s 
 
t
 
 test.
 
Lymphocyte Activation in Culture.
 
Splenic B cells were purified
using B220 microbeads and a Magnetic Cell Sorter (MACS; Mil-
tenyi Biotec). B cells (2 
 

 
 10
 
5
 
/well) were stimulated for 4 d with
50 
 

 
g/ml LPS alone or 50 
 

 
g/ml LPS plus 800 U/ml IL-4 in
RPMI 1640 medium supplemented with 20% FCS, 2-mercapto-
ethanol (ME), penicillin, and streptomycin. Cells and culture super-
natants were analyzed by flow cytometry and ELISA, respectively.
 
RT-PCR.
 
Cells (5 
 

 
 10
 
5
 
/ml) were stimulated in vitro for
2 d with 50 
 

 
g/ml LPS alone or LPS plus 800 U/ml of IL-4. Total
RNA was extracted using TRIzol (GIBCO BRL) according to
the manufacturer’s instructions. For PCR of germline transcripts,
the following standard primers were used to obtain the indicated
sizes of products: (
 

 
) ImF and CmR, 245 bp; (
 

 
3) Ig3F and
Cg3R, 323 bp; (
 

 
1) Ig1 and Cg1R, 429 bp. Post-switch tran-
scripts were amplified using the following primer pairs: (
 

 
3) ImF
and Cg3R, 323 bp; (
 

 
1) ImF and Cg1R, 353 bp. Germline and
post-switch transcripts were amplified using 30 cycles of PCR.
The primer sequences were as follows: ImF; 5
 

 
-CTCTGGC-
CCTGCTTATTGTTG-3
 

 
, CmR: 5
 

 
-GAAGACATTTGG-
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GAAGGACTGACT-3
 

 
, Ig3F: 5
 

 
-TGGGCAAGTGGATCT-
GAACA-3
 

 
, Cg3R: 5
 

 
-CTCAGGGAAGTAGCCTTTGACA-
3
 

 
, Ig1: 5
 
-GGCCCTTCCAGATCTTTGAG-3, Cg1R: 5-
GGATCCAGAGTTCCAGGTCACT-3.
For amplification of the AID transcript, the primer pair of
5-GAGGGAGTCAAGAAAGTCACGCTGGA-3 and 5-GG-
CTGAGGTTAGGGTTCCATCTCAG-3 was used in 30 cy-
cles of PCR. For amplification of MSH2 transcripts, the primers
5-CTAAGGAGACGCTGCAGTTG-3 and 5-TACTGGC-
GAACCAGAAGAAG-3 were used. For amplification of the
HPRT transcript, the primers 5-GATTAGCGATGATGA-
ACCAGG-3 and 5-ACAGTAGCTCTTCAGTCTGATA-3
were used.
Digestion-Circularization-PCR. Digestion-circularization (DC)-
PCR analysis was performed as described (25). Briefly, genomic
DNA was isolated from B cells cultured in vitro for 4 d with LPS
(50 g/ml) and IL-4 (800 U/ml). After EcoRI digestion, geno-
mic DNA was purified and self-ligated. Ligated DNA was puri-
fied and used as a template for PCR using primers as reported
previously for -1 (25).
B Cell Proliferation. Splenic B cells were purified using B220
magnetic beads and CD23lowCD21high cells or CD23highCD21low
cells were isolated by cell sorting. Purified cells (105) were placed
into round-bottomed 96-well plates in RPMI 1640 medium con-
taining 10% FCS. Anti-IgM (50 g/ml; ICN Biomedicals/Cap-
pel), IL-4 (100 ng/ml; PeproTech), anti-CD40 (5 g/ml; BD
Biosciences), LPS (2.5 g/ml; Sigma-Aldrich) or PDBu (20 ng/
ml; Sigma-Aldrich) plus ionomycin (2 g/ml; Sigma-Aldrich)
were added to cultures. Cells were harvested on day 2 after a 12 h
pulse with 1Ci [3H]thymidine (Amersham) per well.
Apoptosis of “Small Dense” B Cells. Anti-Ig antibody was im-
mobilized by incubating PBS containing 100 g/ml F(ab)2 frag-
ments of affinity-purified goat anti–mouse IgM antibody (ICN
Biomedicals) in wells of plastic dishes at 37C overnight, followed
by washing with PBS. “Small dense” B cells were prepared by de-
pleting T cells from mouse splenocytes using anti-Thy1.2 F7D5
(Serotec), anti-CD4 RL172.5 (a kind gift of Dr. Kina, Kyoto
University, Kyoto, Japan), anti-CD8 3.155 (American Type Cul-
ture Collection no.TIB211) and Low-Tox-M rabbit complement
(Cedarlane), followed by fractionation using density gradient cen-
trifugation through Percoll (BD Biosciences). Small dense B cells
were then cultured in dishes containing immobilized anti-Ig anti-
body in RPMI 1640 medium supplemented with 10% FCS, 50
M 2-ME, and 2 mM l-glutamine for up to 24 h. The percent-
age of viable cells was determined by trypan blue exclusion. Via-
bility results were calculated as a comparison of the percentage of
viable cells remaining after treatment relative to the viability of
untreated cells cultured for the same length of time.
B Cell Migration Assay. Splenic B cells (106) purified using
B220 magnetic beads were assayed for transmigration using a 6.5
m diameter, 3 m pore size transwell culture dish insert (Co-
star). Migration was allowed to proceed for 3 h from the top
chamber containing RPMI supplemented with 0.25% human se-
rum albumin to the bottom chamber containing 0–300 ng/ml of
human stromal cell–derived factor (SDF)-1	 (R&D Systems).
Cells before and after migration were stained for CD23 and
CD21/35 as described above and counted with a FACScan™.
The percent change in the populations of each chamber after mi-
gration was calculated as (the percent of CD21highCD23low or
CD21lowCD23high cells in the chamber after migration)/(the per-
cent of these cells in the chamber before migration)  100%.
Results
Generation of B Cell-specific Pten-deficient Mice. B cell–
specific Pten-deficient mice (bPtenflox/flox mice) were gener-
ated by crossing CD19Cre transgenic mice (22) to mice
homozygous for the floxed Pten allele (Ptenflox/flox mice; ref-
erence 11). bPtenflox/flox mice were born alive and appeared
healthy. Genomic Southern blotting showed that, in the
vast majority of mutant B cells, Cre-mediated recombina-
tion of loxP sites deleted much of the 6.0 kb Ptenflox allele,
leaving the 2.3 kb Pten
 allele (Fig. 1 A). The deletion of
Figure 1. Generation of B
cell–specific Pten deficient
(bPtenflox/flox) mice and analysis
of enlarged lymphoid organs. (A)
Genomic Southern blot. DNA
(20 g) was extracted from the
indicated cells, digested with
HindIII, and hybridized to a pre-
viously described probe (refer-
ence 11). The vast majority of B
cells from CD19CrePtenflox/flox
mice (bPtenflox/flox mice) showed a
B cell–specific deletion of the
Pten gene. (B) Western blot
analysis of Pten protein from the
indicated cells using Pten anti-
body and control actin anti-
body. (C) Splenomegaly, lymph
node swelling, and abundant
peritoneal cells in bPtenflox/flox
mice. Results shown are the ab-
solute numbers of splenocytes
(Spleen), mesenteric lymph node
cells (MLN), bone marrow cells
(BM), and cells in the PEC from
6–8-wk-old bPten/ (n  3),
bPtenflox/ (n  3), and bPtenflox/flox (n  3) mice. Where appropriate in all figures, the results are expressed as the mean  SEM of the indicated number
of mice per group. Statistical differences in all cases were determined using the Student’s t test; *P  0.05.
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Pten was confirmed at the protein level by Western blot-
ting using antibody recognizing the NH2 terminus of Pten
(Fig. 1 B). The frequencies of gene deletion observed in
B220dull CD5 peritoneal cavity (PEC) cells and B220
spleen cells were comparable (unpublished data). The
health of 30 bPtenflox/flox mice and 30 control CD19
CrePten/ (bPten/) mice was monitored for over 12 mo.
All mutant mice survived the observation period and no
tumor formation was observed.
Altered B Cell Populations. bPten/ and bPtenflox/flox
mice were killed at 6–8 wk of age, and B cell subpopula-
tions in the spleen, mesenteric lymph nodes (MLNs), bone
marrow (BM), and PEC were examined. Total numbers of
splenocytes, MLN cells, and PEC cells in bPtenflox/flox mice
were increased 2.0-fold, 1.9-fold, and 5.5-fold, respectively
(Fig. 1 C). Although PTEN is expressed in WT pro-B cells
and pre-B cells as well as in mature B2 cells, there were no
obvious differences in either the total number of BM cells,
or in numbers of pro-B cells (CD43, B220, IgM) or
pre-B cells (CD43, B220, IgM) in the BM of WT and
mutant mice (unpublished data).
The increased B cell number in the PEC was due to a
24-fold increase in CD5dullB220dull cells (Fig. 2 A, top
panel; Fig. 2 B, left). These cells expressed Mac-1low,
CD21, CD23, and HSA, compatible with the surface
phenotype of B1a cells (unpublished data; references 26
and 27). CD5dullB220dull cells were also increased 11-fold in
the spleens of bPtenflox/flox mice compared with bPten/
spleens (Fig. 2 A, bottom panel; Fig. 2 B).
As shown in Fig. 2 C, IgMIgD B cells were also ele-
vated in bPtenflox/flox spleens. Although CD5dull B220dull cells
belong to the IgMIgD population, the increase in their
numbers could account for only a part of this eleva-
tion. WT splenic IgMIgD B cells include MZB cells
(CD21highCD23low), a population that was dramatically in-
creased in bPtenflox/flox mice (Fig. 2, D, F, and G). FOB cells
(CD21lowCD23high) were decreased not only in relative
number (Fig. 2 D), but also in absolute number (Fig. 2 G).
Immunohistochemical staining revealed that most of the B2
cells were located in marginal zones, while only a few ap-
peared to be in follicular regions in the bPtenflox/flox spleen
(Fig. 2 E). A similar skewing of cell numbers was noted in
bPtenflox/flox lymph nodes (unpublished data). The percent-
age of total lymph node B lymphocytes that were
CD21highCD23low was 5.2  1.1% in the WT and 31.8 
2.9% in the mutant, while the percentage of CD21low
CD23high cells was 66.4  2.0% in the WT and 23.94 
1.8% in the mutant. In contrast, the absolute numbers
of transitional T1 (IgMCD21lowCD23low) and T2 cells
(IgMCD21 high CD23high) in the bPtenflox/flox spleen were
increased to the same extent as total B cell numbers (Fig. 2
G), although the relative number of T1 cells in the CD23low
Figure 2. Pten deficiency alters B1a, MZB. and FOB B cell subsets. (A and B) Accumulation of B1a cells in bPtenflox/flox mice. Increased numbers of
CD5dullB220dull cells in the PEC and spleen of 6–8-wk-old bPtenflox/flox mice were apparent when analyzed by either flow cytometry (A) or total cell
counts (B). (C) Increased IgMIgD cell numbers in the bPtenflox/flox spleen. Levels of surface IgM and IgD were determined by flow cytometry. (D–F) Al-
terations to B cell subsets. Flow cytometric (D and F) and total cell count (G) analyses were used to evaluate mature IgMCD21highCD23low cells (puta-
tive MZB cells; D and F) and IgMCD21lowCD23high cells (putative FOB cells; D), and transitional IgMCD21lowCD23low cells (putative T1 cells; F) and
IgMCD21highCD23high (putative T2 cells; F) among splenic B cells of 6–8-wk-old bPtenflox/flox and bPten/ mice. Immunohistochemical analysis (E) us-
ing MOMA1 (green) and B220 (red) antibodies shows a dramatic increase in MZB cells among B2 cells in bPtenflox/flox mice, while the number of FOB
cells is markedly reduced. For B and E, results are expressed as the mean  SEM for 6 mice per group. For A, C, D, E, and F, one result representative
of seven independent experiments is shown.
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population was significantly reduced (Fig. 2 G). The overall
segregation of T cell and B cell zones was not impaired
in the splenic white pulp, MLN, or Peyer’s patches of
bPtenflox/flox mice (unpublished data). Thus, B cell–restricted
Pten deficiency results in discrete alterations to the B1a,
MZB, and FOB subsets of B lymphocytes.
Impaired Humoral Immunity. To determine whether the
altered B cell populations in the mutant mice affected hu-
moral immunity, we assessed serum Ig levels in bPtenflox/flox
mice at 8 weeks of age. As shown in Fig. 3 A, marked de-
creases in most IgG subclasses and IgA were observed in
bPtenflox/flox mice compared with bPten/ mice. In contrast,
serum IgM levels in bPtenflox/flox mice were elevated fourfold
over normal.
We then examined the humoral responses of bPten/
and bPtenflox/flox mice immunized with either the thy-
mus-dependent (TD) antigen NP-CG (nitro-phenylacetyl-
chicken -globulin) or the thymus-independent antigen
(TI) type II NP-Ficoll. Production of antigen-specific IgG
in response to TD antigen was dramatically decreased in
bPtenflox/flox mice (Fig. 3 D) as was germinal center forma-
tion (Fig. 3, B and C). Production of antigen-specific IgG
in response to TI-II antigen was also severely impaired in
the absence of Pten (Fig. 3 E). Thus, an absence of Pten
impairs both TD and TI IgG responses.
Reduction of CSR. Because of the altered serum Ig pro-
file observed in bPtenflox/flox mice, we examined isotype
switching in vitro in bPtenflox/flox B cells. bPten/ and
bPtenflox/flox B cells were cultured for 4 d in the presence of
the nonspecific B cell stimulator LPS with or without IL-4.
Trypan blue exclusion analysis confirmed that the viability
of stimulated cells of both genotypes was not significantly
different (unpublished data). Stimulated cells were surface-
stained with anti-IgG1 or anti-IgG3 antibody and sub-
jected to flow cytometric analysis. LPS plus IL-4, but not
LPS alone, induced switching to IgG1 in WT cells (Fig. 4
A). Prolonged stimulation of WT cells with LPS alone in-
duced switching to IgG3 which was down-regulated by
Figure 3. Reduced antigen-specific IgG production and germinal center formation in bPtenflox/flox mice. (A) Serum immunoglobulin levels of unimmu-
nized 8-wk-old mice. Serum IgM was increased in bPtenflox/flox mice while most IgG subclasses and IgA were decreased compared with the WT. (B and
C) Germinal center formation. After injection of TD-antigen (NP-CG), the number of germinal centers was markedly reduced in bPtenflox/flox mice as de-
termined by H&E staining (B, top panel); PNA staining (B, bottom panel); and total counts (C). For C, the total number of germinal centers per spleen
section was plotted. Magnification in B, 10. (D) Production of TD antigen-specific IgGs. Serum levels of specific IgGs induced by injection of NP-CG
were significantly decreased in bPtenflox/flox mice. (E) Production of TI antigen-specific Igs. Serum levels of specific IgGs induced by injection of TI anti-
gen (NP-Ficoll) were also strikingly diminished in bPtenflox/flox mice. Results are expressed as the mean  SEM for six mice per group.
T
h
e 
Jo
u
rn
al
 o
f 
E
xp
er
im
en
ta
l 
M
ed
ic
in
e
662 Critical Roles of Pten in B Cell Homeostasis
the addition of IL-4. These aspects of isotype switching
were reduced in bPtenflox/flox B cells, a result confirmed by
ELISA analysis of culture supernatants (Fig. 4 B).
Isotype switching depends on transcription of class-spe-
cific mRNAs in which the I exon is spliced onto the 5
exon of another CH gene (28). Specific immunoglobulin
transcripts can be identified by RT-PCR using primers
specific for each CH gene (29). We stimulated bPtenflox/flox
spleen cells with LPS plus IL-4 and observed that, while
transcription of germline transcripts was intact, there was a
dramatic reduction in I-C3 and I-C1 post-switch
transcripts (Fig. 4 C). These results imply that Pten defi-
ciency leads to a defect in CSR.
CSR depends in part on the activity of AID, a member
of the RNA-editing cytidine deaminase family. AID was
recently reported to regulate CSR (21) and is activated by
LPS in vitro as well as by antigens in vivo. In bPtenflox/flox
mice, AID expression was markedly reduced (Fig. 4 C). In
Figure 4. Reduction of CSR associated with impaired induction of AID in Pten-deficient B cells. (A and B) Defect in IgG1 and IgG3 production. B
cells from 8-wk-old bPtenflox/flox and control mice were stimulated with LPS, or LPS plus IL-4, and production of IgG1 and IgG3 on the cell surface (A)
and in culture supernatants (B) was analyzed by flow cytometry and ELISA, respectively. For B, results are expressed as the mean  SEM for three mice
per group. (C) Reduction in post-switch transcripts. IgG1 (bottom panel) and IgG3 (top panel) post-switch transcripts were analyzed by RT-PCR. In-
duction of AID expression was almost absent in bPtenflox/flox B cells. (D) Impaired switching at the DNA level. -1 DC-PCR products were profoundly
diminished in stimulated mutant B cells. (E and F) CSR in isolated CD21highCD23low (MZB) and CD21lowCD23high (FOB) cells. Production of IgG1 and
IgG3 postswitch transcripts and AID expression were reduced in both populations of bPtenflox/flox B cells. Data shown are representative of three indepen-
dent experiments.
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contrast, the expression of MSH2, a mismatch repair gene
also important for CSR (30, 31), was not significantly dif-
ferent in bPten/ and bPtenflox/flox B cells.
To directly examine DNA rearrangement in the Ig lo-
cus, we performed digestion-circularization (DC) PCR of
DNA obtained from splenic B cells stimulated with LPS
plus IL-4. As shown in Fig. 4 D, -1 DC-PCR products
were amplified in DNA from stimulated splenic bPten/ B
cells but diminished in DNA from stimulated bPtenflox/flox B
cells. This result demonstrates that Pten deficiency leads to
a failure in CSR. To rule out the possibility that the ob-
served defect in CSR was due to differences in the relative
numbers of particular cell populations, we examined Ig
production and CSR in purified CD21highCD23low (MZB)
cells and CD21lowCD23high (FOB) cells by ELISA and
RT-PCR. Production of IgG1 and IgG3 in response to
stimulation with LPS plus IL-4 was impaired in both
CD21highCD23low and CD21lowCD23high cells of bPtenflox/flox
mice (Fig. 4 E). Similarly, the synthesis of post-switch tran-
scripts and AID expression were reduced equally in
bPtenflox/flox CD21highCD23low and CD21lowCD23high cells
compared with the WT (Fig. 4 F). These data demonstrate
that Pten is indispensable for CSR, presumably because
Pten regulates the induction of AID expression.
Autoantibody Secretion. Pten deficiency has been previ-
ously associated with autoimmunity (10, 11), and B cell–
specific Pten-deficient mice have increased numbers of
autoantibody-producing B1 cells (15). We therefore exam-
ined serum autoantibody titers of bPtenflox/flox mice at 6–8
wk and 6–8 mo of age. Both age groups of mutant mice
produced significantly greater amounts of anti-ssDNA IgM
Ab compared with bPten/ mice in both absolute and rel-
ative (% ssDNA/total IgM) terms (Fig. 5). While the abso-
lute amount of anti-ssDNA IgG Ab was not increased sig-
nificantly in bPtenflox/flox mice, the relative amount of IgG
autoantibody (% ssDNA/total IgG) was elevated. The ob-
served impairment of CSR may partially mitigate the ele-
vation of IgG autoantibodies in bPtenflox/flox mice.
Resistance to Apoptosis, Enhanced Proliferation, and Increased
Migration. We next subjected isolated MZB and FOB
populations to various apoptotic, proliferative, and migra-
tory stimuli. “Small dense” bPtenflox/flox B cells treated in
vitro with immobilized anti-IgM were significantly more
resistant to apoptosis than bPten/ small dense B cells (Fig.
6 A), suggesting that the increase in MZB cells in bPtenflox/flox
mice might be due at least in part to enhanced resistance to
apoptosis.
To examine the proliferation of peripheral B cells,
purified splenic CD21highCD23low (MZB) cells and
CD21lowCD23high (FOB) cells were stimulated in vitro as
indicated in Fig. 6 B. Both populations from bPtenflox/flox
mice showed enhanced proliferation compare with the
WT in response to stimuli such as anti-IgM, anti-CD40,
LPS, or PDBu (phorbol-12, 13-dibutyrate) plus ionomy-
cin. Thus, hyperproliferation contributes to the increased
numbers of MZB cells in bPtenflox/flox mice.
Dammers et al. have reported that MZB cells are derived
from a subset of FOB cells by migration (32), although the
origin of MZB cells remains controversial. If an absence of
Pten enhanced the migration of FOB cells such that more
of them became MZB cells, one would expect to see de-
creased numbers of FOB cells and correspondingly in-
creased numbers of MZB cells, just as we observe in bPtenflox/flox
mice. To test FOB migration, we used transwell migration
Figure 5. Autoantibody secre-
tion by Pten-deficient B cells.
Concentration of serum anti-
ssDNA autoantibodies of the IgM
class (top panel) and IgG class
(bottom panel) in 6–8-wk-old
mice (left panel) and 6–8-mo-
old mice (right panel) as deter-
mined by ELISA. Pten-deficient
mice in both age groups pro-
duced significantly greater
amounts of anti-ssDNA IgM Ab
in both absolute and relative (%
ssDNA/total IgM) terms. While
the absolute amount of anti-
ssDNA IgG Ab was not in-
creased in the mutant mice, the
relative amount of IgG autoanti-
body was elevated. Results are
expressed as the mean  SEM
for eight mice per group.
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assays to measure the induction of directed cellular migra-
tion of purified splenic B cells in a gradient of the chemo-
kine SDF-1	 (stromal cell–derived factor-1	). As shown in
the left panel of Fig. 6 C, the migration of Pten-deficient B
cells was consistently greater than that of controls, even in
the absence of SDF-1	.
To clarify which cell population, MZB or FOB, was re-
sponsible for the enhanced splenic B cell migration, the
percent change in these cell populations before and after
migration was calculated (Fig. 6 C). In bPten/mice,
CD21highCD23low cells were more mobile than CD21low
CD23high cells, consistent with a previous report (33). In
contrast, CD21lowCD23high cells from bPtenflox/flox mice were
much more mobile than either CD21lowCD23high cells or
CD21highCD23low cells from bPten/ mice. These data
suggest that the reduction in the FOB population in
bPtenflox/flox mice can be attributed to the enhanced migra-
tion properties of these cells.
Activation of PKB/Akt. Regulation of PKB/Akt activa-
tion by Pten is critical for normal apoptosis in MEF and for
proliferation/apoptosis in T cells (7, 11). We therefore ana-
lyzed the phosphorylation of PKB/Akt in bPtenflox/flox
splenic B cells. After stimulation with anti-IgM, densito-
metric analysis showed that phosphorylated PKB/Akt was
significantly elevated in bPtenflox/flox B cells compared with
bPten/ B cells (Fig. 7 A). Furthermore, phosphorylation
was completely abolished in both bPten/ and bPtenflox/flox
B cells by the addition of an optimal amount of either of
the PI3K inhibitors wortmannin or LY294002. As shown
in Fig. 7 B, the abnormal activation of PKB/Akt was ob-
served in both B cell subsets in bPtenflox/flox spleens. Thus, in
both MZB and FOB cells, as in T cells and MEF, PKB/
Akt is activated via a PI3K-mediated pathway that is sub-
ject to negative regulation by Pten.
Discussion
To continue our studies of the important tumor suppres-
sor Pten, we have generated and characterized B cell–spe-
cific Pten-deficient mice. To our surprise, bPtenflox/flox mice
have shown no signs of B cell malignancies, although most
T cell–specific Pten-deficient mice develop T cell lympho-
mas (11), and Pten mutations occur in human sporadic B
cell malignancies (12–14). We have initiated the crossing of
bPtenflox/flox mice into the p53 null genetic background to
better assess the onset of B cell malignancy in the absence
of Pten.
In this study, bPtenflox/flox mice showed an increase in
MZB cells and a decrease in FOB cells, suggesting that
Pten is important for the maintenance of normal B cell
subsets in the spleen. It has been proposed that MZB cells
may be derived from a subset of FOB cells that migrates
Figure 6. Resistance to apoptosis, enhanced proliferation, and increased migration of Pten-deficient B cells. (A) Resistance to apoptosis. Small dense B
cells from 8-wk-old mice were stimulated for 24 h with immobilized anti-IgM (100 g/ml). Cell viability was determined by trypan blue exclusion. The
percentage of viable cells remaining after treatment as compared with the viability of untreated cells cultured for the same length of time is shown. The
percentage of viable cells without IgM stimulation: 80  5% (bPten/) and 75  4% (bPtenflox/flox) after 24 h; 48  2% (bPten/) and 56  6% (bPtenflox/flox)
after 48 h. Results are expressed as the mean  SEM for four mice per group. (B) Hyperproliferation. Purified splenic B cells from 6–8-wk-old bPten/
and bPtenflox/flox mice were incubated with the indicated stimuli and proliferation was measured by thymidine uptake. Both CD21highCD23low (MZB) and
CD21lowCD23high (FOB) populations from bPtenflox/flox mice showed enhanced proliferation. Mean thymidine uptake  SEM for three mice per group is
shown. (C) Enhanced migration. Left panel: purified splenic B cells from 6–8-wk-old bPten/ and bPtenflox/flox mice were assayed for transmigration by
culturing them in Transwell culture dish inserts for 3 h in the presence of the indicated concentrations of SDF-1	. The migration of Pten-deficient B
cells consistently exceeded that of the control. The mean number of migrated cells  SEM for three mice per group is shown. Right panel: the % change
in MZB and FOB populations before and after migration in the presence of SDF-1	 (300 ng/ml). CD21highCD23low cells (MZB) from WT and bPtenflox/flox
mice are both highly mobile, but CD21lowCD23high cells (FOB) from Pten-deficient mice are much more mobile than those from the WT. Mean %
change  SEM for three mice per group is shown.
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into an unknown cytokine milieu present outside the folli-
cular zone (32). Knockout studies have shown that Pyk2
(33), Lsc (34), and DOCK2 (35), all molecules involved in
cell motility, are indispensable for MZB formation. The
reduction in FOB cells observed in the absence of Pten
may thus be due to enhanced migration of FOB cells to
this region, where they might become MZB cells or other-
wise enter into the red pulp. CD21highCD23low B cells also
accumulated in bPtenflox/flox lymph nodes, confirming that
Pten-deficient CD21highCD23low B cells have an unusual
recirculation pattern similar to that of WT FOB cells. In
addition, PKB/Akt activation was increased in both MZB
and FOB cells in the absence of Pten. Recently, MZB cells
were reported to be decreased in mutant mice lacking
p110, a subunit of PI3K (36, 37). Thus, PI3K may be a
key molecule responsible for the generation of abundant
MZB cells in bPtenflox/flox mice. We are in the process of
crossing bPtenflox/flox mice to strains lacking various PI3K
structural and regulatory subunits (36–40) to clarify the
contribution of the PI3K/PIP3 pathway to the generation
of MZB cells.
Our data do not formally exclude the possibility that
MZB cells are derived from B cells at the transitional, fetal
or perinatal stages (41–43). The challenge has been to iso-
late sufficient numbers of cells from each of these purified
subpopulations to test in the transplantation assay. Investi-
gations to this end are ongoing.
Like CD40- and CD40L-deficient mice (44, 45),
bPtenflox/flox mice show reduced germinal center formation
associated with impaired B cell activation signaling. Inter-
estingly, these deficits were apparent even in the presence
of strong activation signals delivered via IgM and CD40,
and even though the activation of intracellular signaling
pathways mediated by PKB/Akt and Btk was intact (un-
published data). FOB cells are required to form germinal
centers, and the reduction in this cell population in
bPtenflox/flox mice may account for the observed defect.
Several lines of evidence in this study indicate that CSR
is impaired in bPtenflox/flox mice. First, MZB and B1 cells are
important for TI responses (33, 46), but even though these
populations were elevated in bPtenflox/flox mice, the produc-
tion of antigen-specific IgG in response to TI-II antigen
was profoundly decreased. Second, bPtenflox/flox MZB and
FOB cells showed defective class switching at the cellular
level. Third, Ig germline transcripts were intact in bPtenflox/flox
B cells but the expression of AID, an essential factor for
CSR, was diminished. Little is presently known about the
regulation of AID gene expression and the link between
Pten and AID. It may be germane that mice deficient for
SHIP, a phosphatase whose substrate is also PIP3, have
intact CSR (47). This result implies that the defect in
bPtenflox/flox mice could be PIP3-independent. We are un-
dertaking studies of the transcriptional regulation of the
AID gene to address how Pten might directly or indirectly
influence its expression.
MZB cells are presumed to have a critical role in host
defense against bacterial pathogens (16, 17). However, in
preliminary experiments, no differences were observed be-
tween bPten/ and bPtenflox/flox mice subjected to lethal
Staphylococcus aureus infections. It is possible that, even
though they have greater numbers of the anti-bacterial
MZB cells, the CSR defect in bPtenflox/flox B cells leads to
inadequate host defense.
bPtenflox/flox mice display marked elevations in B1 cell
numbers and serum levels of autoantibodies, particularly
those of the IgM isotype. These B1 cells were CD21 and
CD23 (unpublished data), suggesting that the increase in
the CD21CD23 population in the mutant mice was due
to an increase in B1 cells. Peritoneal B1 cells are involved
in the production of autoreactive antibodies (15) and may
constitute up to 40% of the total IgA-secreting plasma cell
population (48). bPtenflox/flox mice showed reduced serum
IgA and normal titers of IgG autoantibodies in spite of their
increased B1 cells. This phenotype is consistent with the
impaired CSR in Pten-deficient B1 cells. The increase in
the B1 population may be due to the abnormal activation
of the PI3K/PIP3/Akt pathway in bPtenflox/flox mice. Mice
deficient for either the p85	 or p110 subunit of PI3K
show a marked reduction in B1 cells (36–39). Our planned
analyses of p85	/; bPtenflox/flox and p110/; bPtenflox/flox
mice should further define the role of the PI3K/PIP3/Akt
pathway and its regulation by Pten in B1 cell generation
Figure 7. Increased phosphor-
ylation of Akt in Pten-deficient
B cells. (A) Top panel: expression
of phospho-PKB/Akt in total
splenic B cells. Whole cell lysates
were prepared from purified
splenic B cells of 6–8-wk-old
bPten/ and bPtenflox/flox mice.
Cells were stimulated with anti-
IgM for the indicated times. A
total of 20 g extract protein
was subjected to Western blot-
ting to evaluate the expression of phospho-PKB/Akt (top band) and total PKB/Akt (bottom band; control). Increased phosphorylation of PKB/Akt is
evident in extracts of mutant B cells, and this phosphorylation is dependent on PI3K activation as determined by the addition of the PI3K inhibitors
wortmannin (wort) and LY294002 (LY). Bottom panel: densitometric quantitation of phospho-PKB/Akt levels relative to total cellular PKB/Akt. (B)
Top panel: expression of phospho-PKB/Akt in MZB and FOB populations. Increased phosphorylation of PKB/Akt can be seen in Western blot analyses
of extracts of isolated CD21highCD23low and CD21lowCD23high cells. Bottom panel: densitometric quantitation of phospho-PKB/Akt levels relative to to-
tal cellular PKB/Akt. Results shown are representative of three independent experiments.
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and autoantibody secretion. Curiously, despite elevated
levels of autoantibodies, our bPtenflox/flox mice have survived
for over a year without showing definite histological ab-
normalities characteristic of autoimmune disease. This re-
sult stands in contrast to the development of autoimmune
disorders in mice heterozygous for the null Pten mutation
(10) and in T cell–specific Pten-deficient mice (11). Im-
paired CSR may derail the onset of autoimmune disease in
bPtenflox/flox mice.
In conclusion, we have demonstrated that Pten defi-
ciency alters B1, MZB, and FOB B cell subsets in mice.
Moreover, Pten deficiency causes an impairment of im-
munoglobulin isotype switching. Pten is thus an important
regulator of B cell development and homeostasis in the
immune system.
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